What is Veradermics 's accrued liabilities, current?

Veradermics (MANE) reported accrued liabilities, current of $5.61M in Q1 2026.

What does accrued liabilities, current mean?

Short-term expenses that have been incurred but not yet paid.

Veradermics Accrued Liabilities, Current decreased by 19.7% to $5.61M in Q1 2026 compared to the prior quarter.

StatementBalance Sheet Statement

SectionCurrent Liabilities

CategoryLiquidity

SignalContext dependent

VolatilityModerate

First reportedQ4 2025

Last reportedQ1 2026

A steady increase relative to revenue may indicate rising operational costs or changes in payment timing.

These are short-term obligations for expenses that have been incurred but not yet invoiced or paid by the end of the rep...

Standard across all industries for tracking short-term operational obligations.

Metric ID: current_liabilities_accrued_liabilities_current

2 periods

	Q4 '25	Q1 '26
Value	$6.98M	$5.61M
QoQ Change	—	-19.7%

Range$5.61M – $6.98M

What is Veradermics 's accrued liabilities, current?: Veradermics (MANE) reported accrued liabilities, current of $5.61M in Q1 2026.
What does accrued liabilities, current mean?: Short-term expenses that have been incurred but not yet paid.